Company Overview and News

22
10 Financial Stocks to Consider Before They’re No Longer Worth It

13h investorplace
Rising interest rates generally prove a boon for financial stocks, but if turmoil in Turkey turns into an outright contagion that infects the rest of the world, it’s unlikely any sector would be spared regardless of the backdrop. Never mind the fact that the wrong headline can pull the rug out from underneath the market without any warning.
DFS SQ C RF DTK PYPL KEY GS VIRT AMTD ICE ENVA EBAY

0
RF / Regions Financial Corp. FORM 8-K (Current Report)

2018-08-13 sec.gov
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
RF

1
Here’s a conservative economist who doesn’t think Trump fixed everything - MarketWatch

2018-08-10 marketwatch
Peter Morici is one of those conservative economists who doesn’t think Donald Trump has fixed everything. Although he applauds much of Trump’s agenda on taxes and deregulation, he bemoans what he calls a mismanaged trade war and sees a lot of sclerosis in the U.S. economy.
HUSV FGB RAIFY FCM RF HDMV FOVCX RAIFF FEO

0
RF / Regions Financial Corp. 424B2 (Prospectus)

2018-08-10 sec.gov
424B2 Table of Contents Filed Pursuant to Rule 424(b)(2) Registration No. 333-209657 CALCULATION OF REGISTRATION FEE
RF

0
RF / Regions Financial Corp. FWP

2018-08-09 sec.gov
FWP Free Writing Prospectus Filed Pursuant to Rule 433 Registration Statement No. 333-209657 Pricing Term Sheet
RF

0
RF / Regions Financial Corp. 424B2 (Prospectus)

2018-08-08 sec.gov
424B2 Table of Contents Filed Pursuant to Rule 424(b)(2) Registration No.: 333-209657 The information in this preliminary prospectus supplement is not complete and may be changed. A registration statement relating to these securities has been filed with the Securities and Exchange Commission. This prelimi
RF

0
RF / Regions Financial Corp. 10-Q (Quarterly Report)

2018-08-08 sec.gov
Document Table of Contents
RF

27
John's June Dividend Increases And Income Tracker - Retirement Accounts

2018-08-03 seekingalpha
This is the fourth month I have officially tracked dividend income (in an article) for John's Traditional and Roth IRA Accounts. His dividend income totaled $1,186.94.
PK POR SCG CAT XOM HTA RF LTC OPRF TD WMT KMI MSCA SCU OMI WELL KMR TD CVB ORCL BBT VTR DUKH GD NYSE TNTTF MAIN O PACW DUK KMB MSCA.CL PEP CLDT OXY KMRFZ

0
RF / Regions Financial Corp. 8-K (Current Report)

2018-07-30 sec.gov
Document UNITED STATES
RF

7
14 Momentum/Value Stocks

2018-07-30 seekingalpha
This article examines a list of 14 companies that are represented in both the momentum and value indices I have examined recently.
TGT MTUM RF KSS ANDV

6
Quality Over Quantity Paying Off For Regions Financial

2018-07-26 seekingalpha
Revenue growth has been sluggish at Regions, but credit quality is improving and expense leverage has meaningfully improved.
WFC WFCNP RF

0
RF / Regions Financial Corp. 8-K (Current Report)

2018-07-25 sec.gov
Document UNITED STATES
RF

6
Huntington (HBAN) Q2 Earnings Beat Estimates, Revenues Rise

2018-07-25 zacks
Huntington Bancshares (HBAN - Free Report) reported second-quarter 2018 earnings per share of 30 cents, beating the Zacks Consensus Estimate by a penny. Also, the figure came in higher than the prior-year quarter adjusted earnings of 26 cents.
HBANN SBNY HBANO HBANP DB WBSFW SBNYW RF HBAN WBS CIT

Related Articles

BLDP: Ballard Power Systems Analysis and Research Report

2018-08-13 - Asif

Core Business At Ballard, Ballard Power Systems is building a clean energy growth company. Ballard Power Systems is recognized as a world leader in proton exchange membrane (“PEM”) fuel cell power system development and commercialization. The company's principal business is the design, development, manufacture, sale and service of PEM fuel cell products for a variety of applications, focusing on its power product markets of Heavy-Duty Motive (consisting of bus, truck, rail and marine applications), Portable Power, Material Handling and Backup Power, as well as the delivery of Technology Solutions, including engineering services, technology transfer, and the license and sale of its extensive intellectual property portfolio and fundamental knowledge for a variety of fuel cell applications. A fuel cell is an environmentally clean electrochemical device that combines hydrogen fuel with oxygen (from the air) to produce electricity. The hydrogen fuel can be obtained from natural g...

MARA: Marathon Patent Group Analysis and Research Report

2018-08-13 - Asif

Overview Marathon Patent Group was incorporated in the State of Nevada on February 23, 2010 under the name Verve Ventures, Inc. On December 7, 2011, the company changed its name to American Strategic Minerals Corporation and were engaged in exploration and potential development of uranium and vanadium minerals business. In June 2012, the company discontinued its minerals business and began to invest in real estate properties in Southern California. In October 2012, the company discontinued its real estate business when its former CEO joined the firm and the company commenced its IP licensing operations, at which time the Company’s name was changed to Marathon Patent Group, Inc. On November 1, 2017, the company entered into a merger agreement with Global Bit Ventures, Inc. (“GBV”), which is focused on mining digital assets. Marathon Patent Group has since purchased its cryptocurrency mining machines and established a data center in Canada to mine digital assets. Following the me...

ECYT: Endocyte Analysis and Research Report

2018-08-13 - Asif

Business and Organization Endocyte, Inc. is a biopharmaceutical company and leader in developing targeted therapies for the treatment of cancer. The Company uses drug conjugation technology to create novel therapeutics and companion imaging agents for personalized targeted therapies. The agents actively target receptors that are over-expressed on diseased cells relative to healthy cells, such as prostate specific membrane antigen (“PSMA”) in prostate cancer. This targeted approach is designed to safely enable the delivery of highly potent drug payloads. The companion imaging agents are designed to identify patients whose disease over-expresses the target of the therapy and who are therefore more likely to benefit from treatment. In September 2017, the Company entered into a Development and License Agreement (the “License Agreement”) with ABX advanced biochemical compounds – Biomedizinische Forschungsreagenzien GmbH (“ABX”), pursuant to which the Company acquired exclusive ...

CUSIP: 7591EP100